 JUPITER, FL ACCESSWIRE June 29, 2020 Dyadic International, Inc. Dyadic DYAI, a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, announced today that the Company will be added to the small-cap Russell 2000 Index and the broad-market Russell 3000 Index effective after the US market opens on June 29, as a result of the annual Russell index reconstitution. The Russell 3000 Index measures the performance of the largest 3,000 US companies representing approximately 98 of the investable US equity market. 